Table 2 Best response, PFS and OS according to neutropenia grade.
All patients (N = 115) | Neutropenia < 3 (N = 89) | Neutropenia ≥ 3 (N = 26) | p | |
---|---|---|---|---|
PR | 44 (38.3%) | 29 (32.6%) | 15 (57.7%) | 0.06 |
SD | 30 (26.1%) | 23 (25.8%) | 7 (26.9%) | |
DCR (PR + SD) | 74 (64.3%) | 52 (58.4%) | 22 (84.6%) | |
PD | 32 (27.8%) | 29 (32.6%) | 3 (11.5%) | |
NE | 9 (7.8%) | 8 (9%) | 1 (3.8%) | |
PFS | ||||
M-months | 6 | 6 | 7 | 0.08 |
(95% IC) | (5–7) | (5–6) | (5–8) | |
OS | ||||
M-months | 11 | 10 | 13 | 0.04 |
95% IC | (9–13) | (8–13) | (10–18) | |
Cycles | ||||
Median | 5 | 4 | 6 | 0.9 |
Range | 1–17 | 1–17 | 1–17 | |
GCF-prophylaxis | 25 (21.9%) | 11 (12.5%) | 14 (53.8%) | 0.01 |